Last reviewed · How we verify

NCT07292740

Arthroscopic Subscapularis Augmentation

Not yet recruiting Last updated 18 December 2025
What this trial tests

trial in Shoulder Dislocation in 20 participants. Not yet recruiting.

Timeline
1 January 2026
Primary endpoint
1 January 2026
1 September 2026

Quick facts

Lead sponsorAl-Azhar University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment20
Start date1 January 2026
Primary completion1 January 2026
Estimated completion1 September 2026

Conditions studied

Sponsor

Al-Azhar University

Who can join

Adults 18 to 50, any sex, with Shoulder Dislocation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The glenohumeral joint is the most commonly dislocated joint of the human body, The stability of GH joint relies on a complex network of static and dynamic structures. Static stabilizers ::

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Shoulder Dislocation

Currently open trials in the same condition.

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07292740.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing